Drug Combination Details
General Information of the Combination (ID: C83635) | |||||
---|---|---|---|---|---|
Name | Dihydroisotanshinone 1 NP Info | + | Ionizing radiation Drug Info | ||
Disease |
Prostate cancer
[ICD-11: 2C82]
|
Investigative | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Enhancing Drug Efficacy by This Combination | ||||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [1] | |||||
Molecule(s)
Regulation |
Down-regulation | Expression | MSH3 | Molecule Info |
Pathway MAP
|
|
In-vitro Model | DU145 | CVCL_0105 | Prostate carcinoma | Homo sapiens | ||
PC-3 | CVCL_0035 | Prostate carcinoma | Homo sapiens | |||
Experimental
Result(s) |
Dihydroisotanshinone I combined with radiation inhibits the migration ability of prostate cancer cells through DNA damage and CCL2 pathway. |
